From: A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease
Case | Age | Sex | Pathological diagnosis |
---|---|---|---|
Normal 1 | 89 | F | Control case but with Hypoxic-type changes and amyloid angiopathy |
Normal 3 | 80 | F | Control-minimal ageing changes |
AD 1 | 68 | M | Alzheimer’s disease HP-tau stage 6 with mild to moderate amyloid angiopathy |
AD 2 | 93 | F | Alzheimer’s disease HP-tau stage 6 with moderate amyloid angiopathy |
AD 3 | 91 | M | Alzheimer’s disease HP-tau stage 6 with moderate amyloid angiopathy |
AD 4 | 86 | F | Alzheimer’s disease HP-tau stage 6 with mild amyloid angiopathy |
AD 5 | 77 | F | Alzheimer’s disease -modified Braak BNE stage 5 |